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1) It has a surprisingly wide range of beneficial properties, including antiinflammatory, antioxidant, chemopreventive, and chemotherapeutic activities, and has been used to treat several different cancers, including lung carcinomas.
2) However, preclinical and clinical studies have indicated that the poor bioavailability and pharmacokinetic profile of curcumin, due to its instability under physiologic conditions, have limited its application in anticancer therapy. [3] [4] [5] Recently, much research effort has been focused on the chemical modifications of curcumin to generate potential analogues with superior bioavailability and enhanced antitumor activities. [6] [7] [8] [9] [10] To this end, we have designed and synthesized a series of monocarbonyl analogues of curcumin by deleting the reactive b-diketone moiety. 11, 12) Cyclooxygenase-2 (COX-2) is the key enzyme in the conversion of arachidonic acid to protaglandins (PGs) and other bioactive lipids and contributes to the regulation of normal growth responses and aberrant cellular growth. COX-2 overexpression has been associated with poor prognosis in resected lung cancer patients; moreover, lung cancer incidence has been found to be reduced among users of nonsteroidal antiinflammatory drugs. 13) There has also been recent evidence reported that supports COX-2 as a promoter of tumor proliferation, invasive angiogenesis, and resistance to apoptosis in lung cancer. [14] [15] [16] COX-2 inhibitors have been characterized as capable of impeding tumor growth in animal models and of eliciting responses when combined with conventional therapy in phase II clinical trials; furthermore, they have been effectively used as radiosensitizers under chemoradiation conditions. 16, 17) Phorbol 12-myristate 13-acetate (PMA), found in croton oil from the Croton tiglium plant, functions as an environmental tumor promoter and has been reported to upregulate COX-2 expression in human lung cancer cells. 18) Due to the likely correlation between malignancy and COX-2, inhibition of PMA-induced COX-2 expression has become a particularly attractive option for cancer prevention and tumor treatment. Some reports have also indicated that curcumin was able to inhibit PMA-induced COX-2 expression in mouse osteoblastic cells 19) and gastrointestinal epithelial cells. 20) Since PMA-induced COX-2 expression may facilitate tumor formation and progression, curcumin or curcumin analogue mediated inhibition of PMA-induced COX-2 expression merits detailed investigation, especially in relation to human cancer cells. Among the statistics calculated for cancer-related deaths, lung cancer continues to be the leading cause of cancer deaths wide world.
21) The development of innovative new therapeutics for the management of lung cancer is especially urgent.
In this study, we synthesized a new COX-2 inhibitor, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one (GL63), an analogue of curcumin. We also found evidence that GL63 is able to suppress PMA-induced COX-2 expression in a human lung epithelial cancer cell line, H460, more effectively than curcumin. Moreover, we report that GL63 regulates COX-2 expression and is involved in COX-2 mRNA stabilization via the RNA binding protein human antigen R (HuR) subcellular localization and HuR abundance. In conclusion, we generated a new COX-2 inhibitor with potential for clinical therapeutic applications in lung cancer patients. Cyclooxygenase-2 Inhibitor, (1E,4E) Synthesis of GL63 The general procedure used for the synthesis of GL63 is described below. 22) An aliquot of 7.5 mmol of acetone was added to a solution of 15 mmol of arylaldehyde in MeOH (10 ml). The solution was stirred at room temperature for 20 min, followed by dropwise addition of NaOCH 3 /CH 3 OH (1.5 ml; 7.5 mmol). When the reaction was finished, the residue was poured into saturated NH 4 Cl solution and filtered. The resulting precipitate was washed with water and cold ethanol and dried in a vacuum. The solid product was purified by chromatography over silica gel using CH 2 Cl 2 /CH 3 OH (9 : 1) as the eluent to afford the pure product (yield: 59%). Single crystal was checked by thin-layer chromatography (TLC) and 1 H-NMR (Fig. 1 ). Cell Culture and Treatment H460 cells were cultured in RPIM-1640 medium containing 10% heat-inactivated FBS, penicillin 100 U/ml and streptomycin 100 mg/ml (Mediatech Inc., Manassas, VA, U.S.A.) at 37°C with 5% CO 2 (Steri-Cult CO 2 Incubator; Thermo Forma Co., Waltham, MA, U.S.A.). Cells were subcultured upon reaching 100% confluence. GL63 and curcumin were dissolved in DMSO. H460 cells were pretreated with PMA (50 nM) for 1 h to induce COX-2 expression and subsequently treated with GL63 and curcumin, which were added the culture medium to final concentrations of 5, 10, or 20 mM.
A New

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
Bromide (MTT) Assay H460 cells were grown in a 96-well plate for 24 h and then treated with different doses of GL63 (5, 10, 20 mM) and curcumin for 24 h or 48 h, followed by MTT treatment (5 mg/ml) of the cells in each well for 4 h at 37°C. MTT was aspirated and 100 ml of DMSO was added to each well. Absorbance at 570 nm was read in a plate reader. Each treatment was carried out in triplicate, and the results are expressed as percentages of the respective control.
RNA Isolation and Real-Time Quantitative Polymerase Chain Reaction Total cellular RNA was isolated from H460 cells after treatment with GL63, curcumin, or vehicle control for 24 h using an Ambion RNAqueous kit. Total RNA (10 mg) was used for first-strand cDNA synthesis using the High-Capacity cDNA archive kit. The mRNA levels of COX-2 were quantified using the specific gene expression assay kits for human COX-2 on a DNA Engine Opticon2 Sequence Detection System (MJ Research, Inc. Waltham, MA, U.S.A.). The mRNA values of COX-2 in H460 cells were quantified using the following TaqMan primers: forward 5Ј-TGGTGCCTGGTCTGATGATG-3Ј; and reverse 5Ј-GTG-GTAACCGCTCAGGTGTTG-3Ј. iQTM SYBR Green Supermix (Bio-Rad) was used as the fluorescent dye to detect the presence of double-stranded DNA. The mRNA values for each gene were normalized to internal control b-actin mRNA. The ratio of the normalized mean value for each treatment group to the vehicle control group (DMSO) was calculated.
Assessment of COX-2 mRNA Stability H460 cells were pretreated with PMA for 1 h to induce COX-2 production, then GL63 (20 mM) and curcumin (20 mM) or vehicle were added and incubation was carried out for 2 h before the addition of dactinomycin (5 mg/ml) (time 0). Total cellular RNA was extracted 0, 1, 2, 3, and 4 h after dactinomycin addition. COX-2 mRNA levels were determined using real-time polymerase chain reaction (RT-PCR) as described above, and the results are expressed as the percentage of mRNA amount at the time of actinomycin D addition.
Western Blot Analysis After drug treatment, the culture medium was collected, and the cells were washed with icecold phosphate buffered saline (PBS). Whole cell lysates were prepared using lysis buffer containing NaCl 150 mM, 1.0% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS), Tris 50 mM, pH 8.0, and protease and phosphatase inhibitors. Nuclear and cytosolic extracts were isolated as previously described.
23) The protein concentration was measured using Bio-Rad protein assay reagent. The total cell lysate (50 mg of protein), cytoplasmic proteins (30 mg) or nuclear proteins (15 mg) were resolved on 10% Bis-Tris Criterion XT gels (Bio-Rad) and transferred onto nitrocellulose membranes. Immunoblots were blocked with 5% nonfat milk in Tris-buffered saline (TBS) for 1 h at room temperature and then incubated with primary antibodies against COX-2, HuR, Lamin B, or actin at 4-8°C overnight. Immunoreactive bands were detected using HRPconjugated secondary antibodies with the Western Lightning Chemiluminescence Plus reagent. The density of the immunoreactive bands was digitally analyzed using ImageJ computer software (rsbweb.NIH.gov).
COX-2-3-Untranslated Region (3-UTR) Reporter Gene Assay For the reporter activity assay, plasmids that contained the full-length COX-2 3Ј-UTR fused to the green fluorescent protein (GFP) gene (pEGFP-C3 vector) were employed as pEGFP-COX-2-3Ј-UTR. H460 cells were transfected following the instructions of the manufacturer. A total of 5ϫ10 5 cells were seeded in 24-well plates. Following the transfection, incubation was continued for 24 h, followed by individual stimulation with either GL63 or curcumin. GFP activity was determined at the indicated time points. GFP values were normalized with sample protein concentration.
Statistical Analysis All assays were repeated at least three time and levels of all parameters were expressed as meanϮstandard error (S.E.). Statistical comparisons between cells treated with GL63 and curcumin versus control were performed with the t-test and one-way ANOVA. Graphpad Prism 5.0 was used for all statistical tests. Statistical significance was considered to have been reached at pϽ0.05.
RESULTS
Effect of GL63 and Curcumin on COX-2 Protein Expression and mRNA Level in H460 Cells
Endogenous COX-2 expression was very low in H460 cells, and PMA 50 nM induced COX-2 expression in H460 cells in a time-dependent manner ( Fig. 2A) . We tested the effects of GL63 and curcumin on PMA-induced COX-2 mRNA levels and its protein expression. We found that GL63 significantly reduced the level of COX-2 protein at concentrations of 10 and 20 mM, whereas curcumin treatment did not cause any change in COX-2 expression, even when used at 20 mM (Figs. 2B, D) . We also found that GL63 inhibited COX-2 expression in a time-dependent manner (Figs. 2C, E) . RT-PCR was used to verify the effects of GL63 on PMA-induced COX-2 mRNA expression. Under identical experimental conditions employed in the protein study, GL63 significantly reduced the mRNA level of COX-2 in H460 cells at the concentration of 10 mM, while curcumin only slightly and not significantly reduced the mRNA level of COX-2 treatment up to 20 mM (Fig.  3A) . The time course of COX-2 mRNA level also showed the same result after treatment for 6 h (Fig. 3B) . Collectively, these results indicate that GL63, as a new analogue of curcumin, can potently inhibit the expression of COX-2 at both the mRNA and protein levels.
Effect of GL63 and Curcumin on Cell Proliferation in H460 Cells
To determine the effects of the COX-2 inhibitor GL63 on H460 cells, cell viability was examined in the MTT assay. H460 cells were pretreated with PMA 50 nM for 1 h, followed by GL63 or curcumin treatment for 24 h. As shown in Fig. 4A , no significant cytotoxicity was observed in the presence of PMA 50 nM with or without curcumin or GL63 in H460 cells. Figure 4B shows that GL63 and curcumin 20 mM did not inhibit H460 cells proliferation compared with DMSO control. We also counted the cell numbers in controls with or without PMA treatment for 24 h in 96-well plates and they totaled 1.7Ϯ0.3ϫ10 4 and 1.6Ϯ0.3ϫ10 4 , respectively.
GL63 Decreases COX-2 mRNA Stability in H460 Cells
We measured the effects of GL63 and curucmin on COX-2 mRNA degradation in the dactinomycin assay. 24) H460 cells were exposed to PMA with GL63 or curcumin for 4 h, and thereafter an inhibitor of transcription, actinomycin D (1 mg/ml), or solvent was added the culture. RT-PCR analysis revealed that when transcription was blocked with dactinomycin, the levels of COX-2 mRNA decreased more rapidly in GL63-treated cells than in curcumin-treated cells. The half-life of COX-2 mRNA was approximately 3 h in cells treated with curcumin, but it was reduced to less than 1.5 h in cells treated with GL63 (Fig. 5) .
GL63 Reduced Cytoplasmic HuR Protein in H460 Cells Previous studies showed that the 3Ј-UTR of COX-2 1172
Vol. 33, No. 7 mRNA contains AU-rich elements (ARE) that can bind the regulatory protein HuR, a stabilizer of COX-2 mRNA. HuR primarily resides in the nucleus of resting cells, but translocates to the cytoplasm upon COX-2 translocation. We initially investigated whether the different effects of GL63 and curcumin on COX-2 release were correlated with the different effects on the intracellular localization of HuR. As shown in Fig. 6 , GL63 decreased cytoplasmic HuR levels and generated a corresponding increase in nuclear HuR levels; however, total cellular HuR levels showed almost no change. In contrast, curcumin had no significant effect on HuR translocation.
GL63 Reduced COX-2-3-UTR in H460 Cells
Taking into account that mRNA stabilization is an important feature of COX-2 regulation, we performed GFP reporter assays using the COX-2-3Ј-UTR GFP reporter plasmids. In these plasmids, the full-length COX-2-3Ј-UTR region was fused to the GFP gene. GFP expression was therefore anticipated to be indicative of increased or decreased 3Ј-UTR mediated COX-2 mRNA stabilization. H460 cells transfected with pEGFP-C3 plasmid plus COX-2-3Ј-UTR and treated with PMA, GL63, and curcumin revealed a dose-dependent decrease compared with controls. In contrast, curcumin produced no significant effects on the expression of GFP in this in vitro reporter system (Fig. 7) . We concluded that the decreased COX-2 translation and expression might attribute to a COX-2-3Ј-UTR-dependent mRNA stabilization mechanism in H460 cells. H460 cells were pre-treated with PMA 50 nM for 1 h, then DMSO, GL63 (20 mM) or curcumin (20 mM). After 2 h incubation, dactinomycin was added the cell culture to stop transcription, and incubations were terminated at the indicated time points (0-4 h). Total RNA was extracted and analyzed using real-time RT-PCR. COX-2 mRNA levels were normalized against b-actin from three separate treatments.
Fig. 6. Effects of GL63 and Curcumin on HuR Cellular Distribution in H460 Cells
H460 cells were pretreated with PMA 50 nM for 1 h, then DMSO, GL63 (20 mM), or curcumin (20 mM) for 24 h. The cytoplasmic (A), nuclear (B), and total cell lysate (C) proteins were probed using Western blot analysis. Lamin B was used as the loading control for nuclear protein, and actin as the loading control for both the total and cytoplasmic proteins. Three experiments were performed and showed similar results. 
DISCUSSION
Preclinical data strongly suggest that overexpression of COX-2 plays a critical role in tumor-mediated angiogenesis, invasion, metastasis, and chemoresistance. The roles of COX-2 in lung carcinogenesis have been extensively studied both in vitro and in vivo. 16, 17) COX-2 inhibition in the context of chemoprevention of lung cancer has garnered a special amount of research interest; recent clinical studies have demonstrated that the use of selective COX-2 inhibitors results in a significant risk reduction for lung cancer (79% reduction), suggesting that COX-2-blocking agents have great potential for the chemoprevention of lung cancer. 25, 26) Curcumin-mediated regulation of COX-2 expression has been demonstrated as an important mechanism by which curcumin prevents a number of disease processes, including cancer. 27) Moreover, curcumin has been shown to inhibit COX-2 protein in the lung cancer cell line A549, albeit at relatively high concentrations of up to 50 mM. 28) Preclinical and clinical studies have indicated that the poor bioavailability and pharmacokinetic profiles of curcumin, mainly due to its instability under physiologic conditions, have limited its applicability to anticancer therapies. [3] [4] [5] More potent curcumin analogues that can inhibit COX-2 at lower dosages are needed to treat lung cancer more effectively.
Recently, substantial research efforts have been put into the chemical modification of curcumin to generate novel analogues with superior bioavailability and antitumor activities. [6] [7] [8] [9] [10] 29) We have designed and synthesized a series of monocarbonyl analogues of curcumin by deleting the reactive b-diketone moiety. Our preliminary studies indicated that some monocarbonyl analogues not only were able to enhance stability and antitumor activities in vitro but also have better pharmacokinetic profiles in vivo. 11, 12, 22, 30) In this study, we demonstrated that a new analogue, GL63, is more potent than curcumin in inhibiting PMA-induced COX-2 mRNA and protein expression (Figs. 2, 3 ). COX-2 is positively correlated with tumor migration and invasion, 17) although we did not observe significant cytotoxicity of GL63 and curcumin in H460 cells (Fig. 4) . We suggest that GL63 20 mM is not sufficient to inhibit H460 cell proliferation, while GL63 may have inhibitory effects on the migration and invasion of H460 cells mediated through the suppression of COX-2 expression, which needs further research. It was also reported that the anticancer active constitutent dihydroartemisinin (DHA) at 50 mM had no cytotoxicity against human fibrosarcoma HT-1080 cells, but DHA at 50 mM inhibited the PMA-induced invasion of HT-1080 cells. 31) COX-2 expression is regulated at both the transcriptional and posttranscriptional levels, depending on the type of stimulus, cellular context, and presence of transcription factors, such as nuclear factor kappa-B (NF-kB) and cAMP-response element binding protein. 32) In addition, evidence was presented indicating that COX-2 regulation occurs at the level of mRNA stability. COX-2 mRNA possesses a long 3Ј-UTR containing multiple ARE that mediate its stability by interaction with various RNA binding proteins, such as ARE/ poly(U)-binding/degradation factor-1, tristetraprolin, and HuR. 33, 34) HuR has been reported to be involved in the regulation of COX-2 mRNA stability in tumors from colon, uterine/cervical, and ovarian tissues. 35, 36) However, whether COX-2 inhibitors can also regulate the stability of COX-2 mRNA in non-small cell lung carcinoma has not been reported. In the present study, we found that GL63 treatment facilitated COX-2 mRNA degradation, as evidenced by the mRNA degradation assay. The half-life of COX-2 mRNA was reduced from 3 h to less than 1.5 h in cells treated with GL63, while curcumin only slightly reduced the half-life of COX-2 as compared with the DMSO-treated group (Fig. 5) .
Although the precise mechanisms regulating HuR expression are still unclear, its localization in the cytoplasm or nucleus is crucial for its function. Under normal conditions, HuR is predominantly present in the nucleus; in response to various stimuli, HuR can be shuttled between the cytoplasm and nucleus. 36, 37) Because GL63 reduced COX-2 mRNA stability, we measured the effects of GL63 on HuR protein levels. Our data demonstrated that GL63, but not curcumin, decreased the translocation of HuR from the nucleus to cytoplasm (Fig. 6) . It has been confirmed that, as an mRNA-stabilizing factor, HuR is able to bind the 3Ј-UTR of COX-2 mRNA, which in turn promotes COX-2 expression. Sequestration of HuR in the cytoplasm may explain, at least in part, the ability of GL63 to destabilize COX-2 mRNA. Furthermore, the COX-2-3Ј-UTR GFP reporter gene confirmed the activity of GL63. GL63 decreased PMA-induced COX-2-3Ј-UTR GFP values in a dose-dependent manner, as compared with curcumin, a finding that also indicateds that decreasing COX-2 translation and expression might contribute to a 3Ј-UTR of COX-2-dependent mRNA stabilization mechanism in H460 cells (Fig. 7) .
In conclusion, we described a new monocarbonyl analogue of curcumin, GL63, and defined its potent function in inhibiting PMA induced-COX-2 expression in the human lung epithelial cancer cell line H460; these findings suggest that GL63 has promising potential for application as a therapeutic or chemopreventative agent for cancer, particularly of the lung.
